From: Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Characteristic | CU | A− | A+ | T− | T+ | N− | N+ |
---|---|---|---|---|---|---|---|
Number of individuals | 318 | 60 | 50 | 52 | 58 | 67 | 43 |
Sex (% female) | 50% | 51.67% | 48% | 50% | 50% | 50.75% | 48.84% |
Age (y) | 75.66 ± 5.22 | 75.37 ± 5.67 | 76.01 ± 4.67 | 73.87 ± 4.54 | 77.26 ± 5.32b*** | 74.46 ± 4.66 | 77.52 ± 5.55c** |
Education (y) | 15.73 ± 2.83 | 15.42 ± 2.68 | 16.1 ± 2.99 | 15.77 ± 2.77 | 15.69 ± 2.91 | 15.57 ± 3.1 | 15.98 ± 2.37 |
MMSE | 29.08 ± 1.03 | 28.98 ± 1.1 | 29.2 ± 0.95 | 29.13 ± 0.93 | 29.03 ± 1.12 | 29.01 ± 1.05 | 29.19 ± 1.01 |
ADAS-Cog | 6.42 ± 2.92 | 6.09 ± 2.91 | 6.81 ± 2.92 | 6.18 ± 2.85 | 6.64 ± 2.99 | 6.22 ± 2.69 | 6.73 ± 3.27 |
APOE ε4 carriers (%) | 24.55% | 11.67% | 40%a*** | 15.38% | 32.76% b* | 19.40% | 32.56% |